A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain
Completed · Phase 3
Conditions studied: Pain
In brief
The purpose of this study is to evaluate the safety and effectiveness of VX-548 in treating acute pain.
Key facts
- Study ID
- NCT05661734
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 258
- Starts
- 2023-01-09
- Expected to finish
- 2023-12-12
- Last updated by the study team
- 2025-07-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Anaheim Clinical Trials — Anaheim, California, United States
- Trovare Clinical Research | Bakersfield, CA — Bakersfield, California, United States
- Mart Medical Research Group LLC — Miami, Florida, United States
- Mart Medical Research Group LLC — South Miami, Florida, United States
- Atlanta Center for Medical Research | Atlanta, GA — Atlanta, Georgia, United States
- Cypress Surgery Center — Wichita, Kansas, United States
- OrthoNebraska Hospital — Omaha, Nebraska, United States
- Center for Orthopaedic Reconstruction and Excellence — Jenks, Oklahoma, United States
- HD Research LLC | First Surgical Hospital — Bellaire, Texas, United States
- HD Research LLC | Legent Orthopedic Hospital — Carrollton, Texas, United States
- Renovatio Clinical — Houston, Texas, United States
- Futuro Clinical Trials — McAllen, Texas, United States
- South Texas Spine & Surgical Hospital — San Antonio, Texas, United States
- Wasatch Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.